Ragan Paula — SEC Form 4 filings
SEC reporting owner CIK 1769914. 9 Form 4 filings on record with FilingPulse; latest filed 2025-06-27.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-12 to 2025-06-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 451,076 shares, $262,499 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: sale of 239,436 shares @ $0.55 ($131,522) in X4 Pharmaceuticals, Inc, filed 2024-10-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc (XFOR) | President and CEO, Director | 8 | — | 6 legs · 451,076 sh · $262,499 | 4 |
| Camp4 Therapeutics Corp (CAMP) | Director | 1 | — | — | 1 |
Form 4 filings — Ragan Paula
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-06-27 | 4 | Camp4 Therapeutics Corp (CAMP) | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Grant/award (A): 2,250,000 @ $0 | EDGAR |
| 2025-01-27 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Grant/award (A): 169,940 @ $0 · Sale (S): 76,473 @ $0.45 | EDGAR |
| 2024-11-19 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Sale (S): 31,897 @ $0.39 | EDGAR |
| 2024-10-16 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Sale (S): 31,897 @ $0.56 | EDGAR |
| 2024-10-08 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Grant/award (A): 532,081 @ $0 · Sale (S): 239,436 @ $0.55 | EDGAR |
| 2024-03-11 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Sale (S): 49,678 @ $0.88 | EDGAR |
| 2024-02-16 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Grant/award (A): 1,189,578 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Sale (S): 21,695 @ $1.01 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1769914 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →